EN
HI
CORONA Remedies share price chart
CORONA Remedies Share Key Metrics
Volume
18140.00
Market Cap
12836.28 CR
LTQ@LTP
122@2098.80
ATP
2106.59
Var Margin
13.21 %
Circuit Range
1672.9-2509.3
Delivery %
39.73 %
Value
3.82 CR
ASM/GSM
No
Market Lot
1
Summary
CORONA stock price is ₹2098.8 as of 1 Aug, 2026. The stock intraday movement has stayed between ₹2077.60 and ₹2136.00, while CORONA Remedies share price 52 week high low is ₹1336.60 & ₹2145.90.
In terms of trading activity, CORONA share price has recorded a volume of 18,140 shares. The CORONA Remedies has a market cap of ₹61160088. The stock’s Average Traded Price (ATP) stands at ₹2106.59, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 122 @ ₹2098.80.
The CORONA Remedies upper circuit limit is ₹2509.30 & The CORONA Remedies lower circuit limit is ₹1672.90, with a Value of ₹3.82 CR. The Delivery Percentage for the day is 39.73%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
CORONA Remedies Fundamentals
P/E Ratio
64.46
P/B Ratio
17.18
Div. Yield
0.48
Sector P/E
64.5
Sector P/B
3.21
Sec. Div. Yield
0.52
CORONA Remedies Resistance and Support
Pivot 2103.33
Resistance
First Resistance
2133.66
Second Resistance
2176.23
Third Resistance
2206.56
Support
First Support
2060.76
Second Support
2030.43
Third Support
1987.86
CORONA Remedies Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Jul 31 2026 | 2118.2 | 2098.8 | 0.37% | 2136 | 2077.6 |
| Thu Jul 30 2026 | 2110.19 | 2091.1 | -0.77% | 2145.89 | 2073 |
| Wed Jul 29 2026 | 2090 | 2107.39 | 1.82% | 2128.89 | 2063.39 |
CORONA Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-11 | Audited Results & Final Dividend |
| 2026-02-02 | Quarterly Results |
| 2026-01-02 | Quarterly Results |
CORONA Remedies News
Corona Remedies Ltd - 544644 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Corona Remedies delivered strong Q1 FY27 results with revenue growing 21.9% YoY to Rs.422.4 Cr and PAT increasing 30.1% YoY to Rs.60.1 Cr. The company also inaugurated a new EU-GMP approved Female Hormone Manufacturing Facility in Ahmedabad.
Jul 31 2026 17:42:50
Corona Remedies Ltd - 544644 - Board Meeting Outcome for Outcome Of Board Meeting
Corona Remedies reported Q1 FY27 revenue of ₹422.4 cr, up 21.9% YoY, and net profit of ₹60.1 cr, up 30.1% YoY. This growth was supported by brand-building efforts and the inauguration of an EU-GMP approved Female Hormone Manufacturing Facility in Ahmedabad on June 30, 2026.
Jul 31 2026 17:20:17
Read More
CORONA Remedies Management
| Name | Position |
|---|---|
| Kirtikumar Laxmidas Mehta | Chairman |
| Niravkumar Kirtikumar Mehta | Managing Director & Chief Executive Officer |
CORONA Remedies Similar Stocks
Jubilant Pharmova Ltd.
935.15
-26.50 (2.76%)
Dr. Agarwal's Health Care Ltd.
478.00
-4.20 (0.87%)
Rainbow Children's Medicare Ltd.
1525.40
4.80 (0.32%)
Vijaya Diagnostic Centre Ltd.
1344.40
-15.80 (1.16%)
Concord Biotech Ltd.
1420.80
90.80 (6.83%)
Alivus Life Sciences Ltd.
1160.00
64.30 (5.87%)
Metropolis Healthcare Ltd.
582.45
-2.75 (0.47%)
Park Medi World Ltd.
292.65
13.35 (4.78%)
Shilpa Medicare Ltd.
611.25
8.30 (1.38%)
CORONA Remedies FAQs
The Buying Price of CORONA Remedies share is 2098.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy CORONA Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for CORONA Remedies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of CORONA Remedies shares is 64.46. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio CORONA Remedies shares is 17.18. Useful to assess the stock's value relative to its book value.
To assess CORONA Remedies’s valuation compare Sector P/E, P/B which are 64.5 & 3.21 with sector averages, along with growth rates and financial metrics.
The Market Cap of CORONA Remedies is 12836.28 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of CORONA Remedies share price is 2145.90 & 1336.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
CORONA Remedies belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
